In addition, dual HER2 blockade showed a clear trend in improving PFS compared with single-targeted therapy.
← all excerpts
Identifying the optimal therapeutics for patients with hormone receptor-positive, HER2-positive advanced breast cancer: a systematic review and network meta-analysis.
1
—
—